This video is available only for registered users. (Cancel and go back to Homepage)

Register FREE now!
Click Here »

As registered user you will:
  • a) Get full access to videos
  • b) Receive monthly newsletter with stock information
 
Already registered?
Email adress:
Password:
Tue, 26th Jul 2016
It has been a very exciting day for SEC Spa, so says managing director Cesare Valli, as the...
Fri, 10th Jul 2015
Summary of Events
Weekly Wrap - 10th July 2015
Fri, 3rd Jul 2015
Summary of Events
Weekend in Focus - Greek Referendum
Thu, 2nd Jul 2015
Summary of Events
Preview: June Non-Farm Payrolls - 2nd July 2015
Mon, 29th Jun 2015
Summary of Events
Week Ahead - 29th June 2015
Tue, 26th Jul 2016
It has been a very exciting day for SEC Spa, so says managing director Cesare Valli, as the Italian PR firm is marked the first to AIM float since the UK’s Brexit vote. A £3.4mln equity raise brings an injection of funds will be used to bankroll overseas growth. A deal is imminent here in the UK and SEC is also targeting opportunities in France and Poland too. Next year, attention will turn to the US and South America. “We will finance our programme of acquisitions, which is very long. We hope to be able to cover Europe within this year,” he told Proactive Investors. Valli acknowledges that SEC has a “very intense” programme ahead, but, he believes the fast moving company can make it.
SEC spa looks forward to imminent UK deal and European expansion
Tue, 26th Jul 2016
As Harvest Minerals Plc announced it had found enough potash in just 3% of the Arapua project to warrant mining, executive chairman Brian McMaster told Proactive Investors everything is going to plan. A new JORC compliant resource estimate earlier today, for just a small part of the project, confirmed there is more than enough for the start of a trial mining operation. “We needed the JORC to confirm the quantities, based on the drilling we’ve done, and the lab testing just to confirm precisely the grades. But, in terms of the product mixture is consistent with what management had been thinking for some time,” McMaster says. Enough material has been confirmed for the next five years, and the Harvest Minerals boss is confident based on work so far that the rest of the licence area mimics the area drilled to date. “We expect that over the course of time we’ll just continue to roll forward and be able to identify more product as we need it.”
Harvest Minerals boss reveals all is going to plan at Brazilian potash project
Tue, 26th Jul 2016
A new tie-up between AIM peers Abzena and Faron Pharmaceuticals could be a sign of things to come for the former, as it sees the benefits of a recent expansion. The collaboration builds on an earlier partnership, but crucially is supported by Abzena’s acquisition of new manufacturing capabilities. “We’ve been aiming to flesh out our offering to customers like Faron so that we can take their products all the way through from the earliest stages through to manufacturing and for them to use [those products] in clinical trials,” says Abzena chief financial officer Julian Smith. Smith sees the collaboration as the first in a number of new wins, picked up thanks to Abzena’s expanded capabilities.
Abzena’s Julian Smith talks new deals and the benefit of expanded operations
Tue, 26th Jul 2016
Proxama Plc (LON:PROX) boss John Kennedy talks funding plans as the group looks to accelerate its proximity marketing business. “Proximity marketing in general has taken a real lift over the last six months. “We’ve certainly seen an awful lot of traction both from brands and retailers, and actually companies particularly out-of-home media companies that want to participate in our beacon network. Kennedy talks us through the exciting expansion of Proxama’s beacon network, as well as the ongoing process to sell the group’s digital payments business remains an ongoing process.
Proxama boss John Kennedy talks funding plans and expansion in proximity marketing
Tue, 26th Jul 2016
Ormonde Mining managing director Steve Nicol sat down with Proactive Investors to talk us through the busy phase of work currently underway as the development of the Barruecopardo tungsten mine progresses towards completion. Fully funded, fully permitted and on track for a 2017 start up, the Spanish mine is very much the focus for management and investors alike. Importantly, tungsten is in demand. Nicol explains that a major project like Barruecopardo would have to come online every year for supply to keep up with demand – but currently his company is the only one out there with a funded development. “It [Barruecopardo] is fully funded, and it will be coming online in 2017 to feed into the supply shortfall at that time,” he said.
Ormonde Mining’s Steve Nicol upbeat as Barruecopardo tungsten mine continues towards 2017 start up
Tue, 26th Jul 2016
“It has been a great quarter.” That’s the view of Kevin Foo, chairman of Victoria Oil & Gas Plc (LON:VOG), which today revealed rising production and gas sales in its second quarter. Additionally, the Cameroon based gas-firm turned local utility noted that it has now been recouped some 40% of its exploration expenditure on the Logbaba gas field from sales revenues. Speaking to Proactive Investors Foo said the company has kept up its momentum and it continues to progress an expansion to new customers. As well as the downstream progress, the VOG boss also talks about an upcoming drill programme which has big potential.
Victoria Oil & Gas Plc boss Kevin Foo cheers “a great quarter”
Tue, 26th Jul 2016
Tern Plc’s (LON:TERN) revaluation is the most important of all the numbers in this morning’s interim financial results which revealed a huge boost from the Device Authority encryption business. The AIM quoted technology investor’s value on-paper now stands at around £7.5mln, up from just £1.2mln. Cryptosoft, Tern’s main investment, acquired and merged with Device Authority in April and that transaction triggered a rerating of the shareholding (which now equates to £7.12mln of Tern’s asset value). Tern executive chairman Angus Forrest highlights that the newly consolidated business is a ‘first mover’ and has technology that is ‘transformational’ for security in the so-called Internet-of-Things (IoT). In an in-depth interview with Proactive Investors Forrest talks about deals with IT industry leaders such as Intel and Symantec, and the potential within what he describes as ‘the exploding’ IoT sector.
Tern boss Angus Forrest emphasises new value after consolidation of IoT business
Tue, 26th Jul 2016
Having just joined London’s AIM this morning Concepta chief executive Erik Henau talked Proactive Investors through the fertility-focussed medical technology group’s opportunity. Concepta’s soon-to-be-rolled-out product, MyLotus, allows women to monitor their own hormones and analyse data, via smartphone app, in order to reduce the time to conception. The product is already cleared for the Chinese market while the UK and European regulatory approvals are gestating – somewhat aptly Henau currently believes the CE mark is due in nine months. “We are very near getting revenue which for a start up like us is unusual,” Henau added. Highlighting the scale of the opportunity, Henau says that globally 30% of women who decide to try for a baby take more than 6 months to conceive. It is a ‘considerable group’, he added. Concepta shares began trading on London’s AIM market today (Tuesday July 27) following a £3.5mln funding.
Concepta’s Erik Henau highlights potential of technology to help women with unexplained infertility
Tue, 26th Jul 2016
Danish group Unibio aims to be a world leader in its field, it is understandable then that the group has been very busy since they last caught up with Proactive Investors. Unibio, which has a process that uses methane gas to produce animal feed, is currently advancing operations to complete and start-up a new plant in the coming months. Chief executive Henkrik Busch Larsen gave Proactive Investors the lowdown on the group’s growth strategy and he highlights that capturing just 1% of the animal feed protein production market could deliver hundreds of millions of dollars in revenues. Unibio is now at the beginging of its foray into the huge US$500bn - or 1bn tonne per year - market and, as Busch points out, the opening of the plant and the pending start of deliveries to the company’s first client will mark an important catalyst. A public listing is still on the agenda for Unibio, though in the short term it is seeking to raise capital in a pre-IPO funding round.
Unibio to seek pre-IPO funding with new plant in Denmark
Mon, 25th Jul 2016
Having topped up the coffers with a £1.1mln funding for a new acquisition Versarien boss Neill Ricketts says shareholders have liked the group’s plans for its emerging graphene business. “We are extremely well supported, and we’ve got a great shareholder list,” the chief executive said in an interview with Proactive Investors’ Stocktube. Ricketts highlighted that shareholders are on board with the graphene focussed growth plans, and he is now looking forward to transforming the group and accelerating to get graphene products ‘out there’. This morning Versarien announced existing institutional shareholders Henderson Global Investors and Miton Asset Management took shares in what was a fully subscribed placing. The placing shares are being issued at 10p per share.
Versarien boss Neill Ricketts looks forward to accelerating graphene business
Mon, 25th Jul 2016
Having updated investors on key work with a definitive feasibility study for the giant Kun-Manie nickel project Amur Minerals Plc (LON:AMC) boss Robin Young says there are no real surprises but described ‘solid’ progress. “It [Kun Manie] has got a lot of activities going on,” the Amur chief executive said in an interview. He added: “this was a good chance to allow us to present where we stand in all the main key phases of the project, especially looking at metallurgy and again to track our progress as we advance the project towards a production decision and the ultimate construction.” Young told Proactive Investors’ Stock tube that metallurgy is a “very key aspect”, and he also talks through the other elements of the pivotal study which is being targeted for completion by the end of 2017.
Robin Young talks progress at Kun Manie as Amur advances with definitive feasibility
Fri, 22nd Jul 2016
Blood monitoring medical device maker Sphere Medical Holding PLC (LON:SPHR), has appointed renowned medtech distribution firm Burke & Burke as its exclusive distributor of its Proxima products in Italy. Company chief executive officer Dr Wolfgang Rencken said the company was very pleased to have bagged, in a key European market, a partner with considerable experience in point-of-care devices. “Italy is undoubtedly one of the big markets within Europe, right up there alongside UK, Germany and France,” Dr Rencken told Proactive Investors. “We feel it is a big step up and gives us access to this very important market,” he said, adding that the deal was a big endorsement of Proxima 4, the next generation of Sphere’s blood monitoring technology that remains on track to be launched by the end of the year. Meanwhile, the Sphere chief revealed that he is very pleased with progress at the company’s manufacturing facility in Wales. “We managed to get the factory up and running very quickly, and we are now getting ready for prime time, when we launch Proxima 4.”
Sphere Medical getting ready for prime time